Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OCRELIZUMAB Cause Intervertebral disc protrusion? 217 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 217 reports of Intervertebral disc protrusion have been filed in association with OCRELIZUMAB (OCREVUS). This represents 0.4% of all adverse event reports for OCRELIZUMAB.

217
Reports of Intervertebral disc protrusion with OCRELIZUMAB
0.4%
of all OCRELIZUMAB reports
2
Deaths
98
Hospitalizations

How Dangerous Is Intervertebral disc protrusion From OCRELIZUMAB?

Of the 217 reports, 2 (0.9%) resulted in death, 98 (45.2%) required hospitalization, and 3 (1.4%) were considered life-threatening.

Is Intervertebral disc protrusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 217 reports have been filed with the FAERS database.

What Other Side Effects Does OCRELIZUMAB Cause?

Covid-19 (11,454) Fatigue (5,704) Urinary tract infection (3,618) Headache (3,036) Multiple sclerosis (2,609) Asthenia (2,509) Nasopharyngitis (2,479) Gait disturbance (2,384) Pneumonia (2,333) Pain (2,327)

What Other Drugs Cause Intervertebral disc protrusion?

ADALIMUMAB (2,760) ETANERCEPT (751) METHOTREXATE (648) SODIUM OXYBATE (427) PREGABALIN (415) TOFACITINIB (393) UPADACITINIB (384) INTERFERON BETA-1A (295) PREDNISONE (285) SECUKINUMAB (268)

Which OCRELIZUMAB Alternatives Have Lower Intervertebral disc protrusion Risk?

OCRELIZUMAB vs OCRIPLASMIN OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE OCRELIZUMAB vs OCTREOTIDE OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE

Related Pages

OCRELIZUMAB Full Profile All Intervertebral disc protrusion Reports All Drugs Causing Intervertebral disc protrusion OCRELIZUMAB Demographics